Development of a risk prediction model for gastrointestinal adverse events associated with semaglutide administration in patients with type 2 diabetes mellitus

ObjectiveThis study aims to identify the risk factors associated with gastrointestinal adverse events induced by semaglutide in patients with type 2 diabetes mellitus (T2DM) and to develop a predictive risk model.MethodsA total of 215 patients with T2DM admitted to our hospital between June 2022 and...

Full description

Bibliographic Details

Published in:	Frontiers in Endocrinology
Main Authors:	Deyong Yue, Xuesheng Hua, Ling Zhu, Jun Wang, Lihua Gu, Zhengxia Yuan, Wenle Jian, Yirong Chen, Guoliang Meng
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-11-01
Subjects:	semaglutide type 2 diabetes mellitus gastrointestinal adverse events risk prediction model alcohol α-glucosidase inhibitors
Online Access:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1684395/full